Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011 von Chavarri-Guerra, Y, St. Louis, J, Bukowski, A, Soto-Perez-de-Celis, E, Liedke, P.E.R, Symecko, H, Moy, B, Higgins, M, Finkelstein, D.M, Goss, P.E

Volltext

New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole – Analyses from NCIC CTG MA.17 von Liedke, P.E.R, Tu, D, Shepherd, L, Chavarri-Guerra, Y, Pritchard, K.I, Stearns, V, Goss, P.E

Volltext

The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized rats von Goss, P.E, Qi, S, Josse, R.G, Pritzker, K.P.H, Mendes, M, Hu, H, Waldman, S.D, Grynpas, M.D

Volltext

S27 Application of aromatase inhibitors in endocrine responsive breast cancers von Goss, P.E

Volltext

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years von Goss, Paul E, Ingle, James N, Pritchard, Kathleen I, Robert, Nicholas J, Muss, Hyman, Gralow, Julie, Gelmon, Karen, Whelan, Tim, Strasser-Weippl, Kathrin, Rubin, Sheldon, Sturtz, Keren, Wolff, Antonio C, Winer, Eric, Hudis, Clifford, Stopeck, Alison, Beck, J. Thaddeus, Kaur, Judith S, Whelan, Kate, Tu, Dongsheng, Parulekar, Wendy R

Volltext

Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen von Vachon, C.M, Ingle, J.N, Suman, V.J, Scott, C.G, Gottardt, H, Olson, J.E, Goss, P.E

Volltext

Evolving perspectives in contralateral breast cancer von Dawson, L.A., Chow, E., Goss, P.E.

Volltext

0154 TEACH: Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-positive breast cancer von Moy, B, Maltzman, J.D, Rappold, E, Nicolodi, L, Williams, L.S, Goss, P.E

Volltext

P119 Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with ErbB2-overexpressing breast cancer: Tykerb evaluation after chemotherapy... von Moy, B, Maltzman, J.D, Goss, P.E

Volltext

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole von Goss, P.E., Ingle, J.N., Martino, S., Robert, N.J., Muss, H.B., Livingston, R.B., Davidson, N.E., Perez, E.A., Chavarri-Guerra, Y., Cameron, D.A., Pritchard, K.I., Whelan, T., Shepherd, L.E., Tu, D.

Volltext

Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27 von Strasser-Weippl, K., Sudan, G., Ramjeesingh, R., Shepherd, L.E., O'Shaughnessy, J., Parulekar, W.R., Liedke, P.E.R., Chen, B.E., Goss, P.E.

Volltext

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials von Yerushalmi, R., Dong, B., Chapman, J.W., Goss, P.E., Pollak, M.N., Burnell, M.J., Levine, M.N., Bramwell, V.H.C., Pritchard, K.I., Whelan, T.J., Ingle, J.N., Shepherd, L.E., Parulekar, W.R., Han, L., Ding, K., Gelmon, K.A.

Volltext

The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L) von Wasan, K. M., Goss, P. E., Pritchard, P. H., Shepherd, L., Palmer, M. J., Liu, S., Tu, D., Ingle, J. N., Heath, M., DeAngelis, D., Perez, E. A.

Volltext

Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma von Lee, L., Pintilie, M., Hodgson, D. C., Goss, P. E., Crump, M.

Volltext

randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid l... von Cigler, T, Richardson, H, Yaffe, M. J, Fabian, C. J, Johnston, D, Ingle, J. N, Nassif, E, Brunner, R. L, Wood, M. E, Pater, J. L, Hu, H, Qi, S, Tu, D, Goss, P. E

Volltext

randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women von Cigler, T, Tu, D, Yaffe, M. J, Findlay, B, Verma, S, Johnston, D, Richardson, H, Hu, H, Qi, S, Goss, P. E

Volltext

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17 von Ingle, J. N., Tu, D., Pater, J. L., Muss, H. B., Martino, S., Robert, N. J., Piccart, M. J., Castiglione, M., Shepherd, L. E., Pritchard, K. I., Livingston, R. B., Davidson, N. E., Norton, L., Perez, E. A., Abrams, J. S., Cameron, D. A., Palmer, M. J., Goss, P. E.

Volltext

Denosumab Versus Placebo as Adjuvant Treatment for Women With Early-Stage Breast Cancer at High Risk of Disease Recurrence (D-CARE): An in Progress, Phase 3 Clinical Trial von Coleman, R.E., Barrios, C., Bell, R., Finkelstein, D.M., Iwata, H., Martin, M., Braun, A., Ke, C., Maniar, T., Goss, P.E.

Volltext

Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer von Moy, B, Tu, D, Pater, JL, Ingle, JN, Shepherd, LE, Whelan, TJ, Goss, PE

Volltext

A randomized, placebo-controlled trial von Qi, S, Fabian, C.J, Pater, J.L, Richardson, H, Nassif, E, Wood, M.E, Cigler, T, Brunner, R.L, Tu, D, Goss, P.E, Johnston, D, Yaffe, M.J, Ingle, J.N, Hu, H

Volltext